• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围绝经期女性肥胖预测因素的综合评估:一项系统评价与叙述性综述

A comprehensive evaluation of predictors of obesity in women during the perimenopausal period: A systematic review and narrative synthesis.

作者信息

Verma Aditi, Malhotra Anita, Ranjan Piyush, Kumari Archana, Chopra Sakshi, Khan Maroof A, Kaloiya Gauri Shanker, Singh Amandeep, Prakash Bindu, Ahuja Maninder

机构信息

Department of Home Science, University of Delhi, New Delhi, India.

Lakshmibai College, Department of Home Science, University of Delhi, New Delhi, India.

出版信息

Diabetes Metab Syndr. 2024 Jan;18(1):102933. doi: 10.1016/j.dsx.2023.102933. Epub 2023 Dec 23.

DOI:10.1016/j.dsx.2023.102933
PMID:38181722
Abstract

INTRODUCTION

Obesity during perimenopausal transition can be attributed to various factors. Identifying these factors is crucial in preventing obesity and developing effective strategies to manage weight during this phase. This review aimed to systematically understand predictors of obesity during menopausal transition.

METHODS

The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and searched databases like PubMed, Wiley Online Library, and Cochrane Reviews. Cohort and cross-sectional studies in English language assessing obesity among menopausal women were included. The methodological quality was assessed using Joanna Briggs Checklist for critical appraisal. Risk of Bias (RoB) was generated using Review Manager 5.4.1 (RevMan). Identified predictors were assessed for overall quality of evidence using adopted Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

RESULTS

This review encompassed 42 studies, (21 cross-sectional and 21 cohort) with sample ranging from 164 to 107,243 across studies. Higher parity( ≥ 3 children) emerged as a strong predictor of obesity across seven studies, with good-quality evidence. Lower physical activity was another predictor, supported by eight studies with good-quality evidence. Sociodemographic factors like lower education(<8 years or < than college degree), socioeconomic background, menopausal transition, and older age at menarche showed associations with weight gain, with moderate-quality evidence. Lifestyle factors (high-fat consumption, sedentariness, active smoking status, and psychological difficulties) also showed moderate-quality evidence.

CONCLUSION

This review underscores the multifaceted factors associated with obesity during the perimenopausal transition. Identifying these factors will be helpful in prevention and management of obesity among these women.

摘要

引言

围绝经期过渡期间的肥胖可归因于多种因素。识别这些因素对于预防肥胖以及制定在此阶段有效管理体重的策略至关重要。本综述旨在系统地了解绝经过渡期间肥胖的预测因素。

方法

本综述遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南,并检索了如PubMed、Wiley在线图书馆和Cochrane综述等数据库。纳入了以英语进行的评估绝经后妇女肥胖情况的队列研究和横断面研究。使用乔安娜·布里格斯批判性评价清单评估方法学质量。使用Review Manager 5.4.1(RevMan)生成偏倚风险(RoB)。使用采用的推荐分级评估、制定和评价(GRADE)方法评估已识别的预测因素的总体证据质量。

结果

本综述涵盖42项研究(21项横断面研究和21项队列研究),各研究样本量从164至107,243不等。在七项研究中,较高的产次(≥3个孩子)成为肥胖的有力预测因素,证据质量良好。较低的身体活动是另一个预测因素,有八项研究提供了质量良好的证据支持。社会人口学因素,如较低的教育水平(<8年或低于大学学历)、社会经济背景、绝经过渡以及初潮年龄较大,与体重增加有关,证据质量中等。生活方式因素(高脂肪摄入、久坐不动、当前吸烟状态和心理困扰)也显示出中等质量的证据。

结论

本综述强调了围绝经期过渡期间与肥胖相关的多方面因素。识别这些因素将有助于预防和管理这些女性的肥胖问题。

相似文献

1
A comprehensive evaluation of predictors of obesity in women during the perimenopausal period: A systematic review and narrative synthesis.围绝经期女性肥胖预测因素的综合评估:一项系统评价与叙述性综述
Diabetes Metab Syndr. 2024 Jan;18(1):102933. doi: 10.1016/j.dsx.2023.102933. Epub 2023 Dec 23.
2
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
10
Exercise for intermittent claudication.间歇性跛行的运动疗法
Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4.

引用本文的文献

1
Association between dynapenic obesity phenotypes and physical performance in middle-age and older women living in community.社区中老年女性中肌无力性肥胖表型与身体机能之间的关联
Front Nutr. 2024 Sep 25;11:1480284. doi: 10.3389/fnut.2024.1480284. eCollection 2024.